metadoxine
Alcobra axes ADHD drug after Phase 3 failure
January 18, 2017Research and Development ADHD, Alcobra, metadoxine
Israeli-based firm Alcobra is to pull the plug on its experimental attention deficit hyperactivity disorder (ADHD) drug metadoxine after it …
Latest content
October 28, 2026
Acumetis CEO Herspiegel steps down as Burden assumes role
October 27, 2026
